CY1110007T1 - METHOD OF PREPARATION OF ZONISAMID CRYSTALS RELEASED FROM 1,2-Dichloroethane and ZONISAMID CRYSTALS WITH HIGH HIGH DEPTH - Google Patents

METHOD OF PREPARATION OF ZONISAMID CRYSTALS RELEASED FROM 1,2-Dichloroethane and ZONISAMID CRYSTALS WITH HIGH HIGH DEPTH

Info

Publication number
CY1110007T1
CY1110007T1 CY20101100345T CY101100345T CY1110007T1 CY 1110007 T1 CY1110007 T1 CY 1110007T1 CY 20101100345 T CY20101100345 T CY 20101100345T CY 101100345 T CY101100345 T CY 101100345T CY 1110007 T1 CY1110007 T1 CY 1110007T1
Authority
CY
Cyprus
Prior art keywords
crystals
zonisamid
dichloroethane
preparation
released
Prior art date
Application number
CY20101100345T
Other languages
Greek (el)
Inventor
Yoshikazu Ueno
Yasujiro Kimura
Original Assignee
Dainippon Sumitomo Pharma Co., Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=32711361&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CY1110007(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Dainippon Sumitomo Pharma Co., Ltd. filed Critical Dainippon Sumitomo Pharma Co., Ltd.
Publication of CY1110007T1 publication Critical patent/CY1110007T1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/20—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

A process for the preparation of crystals of zonisamide containing residual 1,2-dichloroethane of not more than 5 ppm, by adding an aqueous C<SUB>2-4 </SUB>alcohol to crystals of zonisamide containing residual 1,2-dichloroethane of more than 5 ppm, removing the 1,2-dichloroethane by azeotropic distillation, followed by collecting the precipitated crystals from the residual mixture.
CY20101100345T 2003-01-13 2010-04-16 METHOD OF PREPARATION OF ZONISAMID CRYSTALS RELEASED FROM 1,2-Dichloroethane and ZONISAMID CRYSTALS WITH HIGH HIGH DEPTH CY1110007T1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US34060103A 2003-01-13 2003-01-13
EP03815138A EP1583748B1 (en) 2003-01-13 2003-07-28 Process for the preparation of 1,2-dichloroethane free crystals of zonisamide and the highly pure crystals of zonisamide

Publications (1)

Publication Number Publication Date
CY1110007T1 true CY1110007T1 (en) 2015-01-14

Family

ID=32711361

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20101100345T CY1110007T1 (en) 2003-01-13 2010-04-16 METHOD OF PREPARATION OF ZONISAMID CRYSTALS RELEASED FROM 1,2-Dichloroethane and ZONISAMID CRYSTALS WITH HIGH HIGH DEPTH

Country Status (16)

Country Link
US (3) US20050080269A1 (en)
EP (1) EP1583748B1 (en)
KR (1) KR101004187B1 (en)
CN (1) CN100528849C (en)
AT (1) ATE457304T1 (en)
AU (1) AU2003249010A1 (en)
CY (1) CY1110007T1 (en)
DE (1) DE60331257D1 (en)
DK (1) DK1583748T3 (en)
ES (1) ES2338871T3 (en)
HK (1) HK1081555A1 (en)
IL (1) IL169451A (en)
PT (1) PT1583748E (en)
SI (1) SI1583748T1 (en)
TW (1) TWI331035B (en)
WO (1) WO2004063174A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1913935A1 (en) * 2005-01-21 2008-04-23 Teva Pharmaceutical Industries Ltd Stable pharmaceutical formulations of zonisamide and methods for their manufacture
DE602006014607D1 (en) * 2005-01-21 2010-07-15 Teva Pharma Stable pharmaceutical compositions of zonisamide and process for their preparation
US7268234B2 (en) * 2005-09-16 2007-09-11 Dainippon Sumitomo Pharma Co., Ltd. Method for sulfonation of 1,2-benzisoxazole-3-acetic acid
CN104059120A (en) * 2014-05-27 2014-09-24 上海新华联制药有限公司 Preparation process of high-purity betamethasone acetate

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6033114B2 (en) 1976-12-16 1985-08-01 大日本製薬株式会社 1,2-benzisoxazole derivative
US4172896A (en) * 1978-06-05 1979-10-30 Dainippon Pharmaceutical Co., Ltd. Methane-sulfonamide derivatives, the preparation thereof and composition comprising the same
FR2428033A1 (en) 1978-06-09 1980-01-04 Dainippon Pharmaceutical Co Anticonvulsant omega-sulphamoyl:alkyl-1,2-benzisoxazole derivs. - e.g. prepd. from 1,2-benzimidazole-3-methane sulphonic acid chloride and ammonia
JPS54163823A (en) 1978-06-12 1979-12-26 Dainippon Pharmaceutical Co Antiiepileptic agent based on 33sulphamoylmethyll 1*22benzisoxazole
JPS54163570A (en) 1978-06-12 1979-12-26 Dainippon Pharmaceutical Co Benzooxazole derivative
US4533764A (en) * 1984-03-29 1985-08-06 The Dow Chemical Company Purification of bisphenols by removing residual solvent
GB8607294D0 (en) 1985-04-17 1986-04-30 Ici America Inc Heterocyclic amide derivatives
JPS63150220A (en) 1986-12-15 1988-06-22 Dainippon Pharmaceut Co Ltd Preparation of solid drug for oral administration
US5082669A (en) * 1989-07-20 1992-01-21 Dainippon Pharmaceutical Co., Ltd. Rapid-releasing oral particle pharmaceutical preparation with unpleasant taste masked
US5811547A (en) 1992-10-14 1998-09-22 Nippon Shinyaju Co., Ltd. Method for inducing crystalline state transition in medicinal substance
TW350757B (en) 1994-11-03 1999-01-21 Ciba Geigy Ag Benzisoxazole derivatives and pesticidal compositions containing them
EP1272181A2 (en) 2000-04-13 2003-01-08 Synthon B.V. Modified release formulations containing a hypnotic agent
CA2451728A1 (en) 2001-06-29 2003-01-09 Elan Pharmaceuticals, Inc. Zonisamide use in headache
JP2005506980A (en) 2001-08-30 2005-03-10 テバ ファーマシューティカル インダストリーズ リミティド Zonisamide intermediates and synthesis
US6936720B2 (en) 2002-02-22 2005-08-30 Teva Pharmaceutical Industries Ltd. Method for preparing benzisoxazole methane sulfonyl chloride and its amidation to form zonisamide

Also Published As

Publication number Publication date
US20050080269A1 (en) 2005-04-14
KR101004187B1 (en) 2010-12-24
TWI331035B (en) 2010-10-01
SI1583748T1 (en) 2010-03-31
US6900333B2 (en) 2005-05-31
EP1583748A1 (en) 2005-10-12
WO2004063174A1 (en) 2004-07-29
PT1583748E (en) 2010-03-03
CN1720239A (en) 2006-01-11
EP1583748B1 (en) 2010-02-10
DK1583748T3 (en) 2010-04-19
KR20050098862A (en) 2005-10-12
CN100528849C (en) 2009-08-19
HK1081555A1 (en) 2006-05-19
AU2003249010A1 (en) 2004-08-10
ATE457304T1 (en) 2010-02-15
IL169451A (en) 2010-12-30
US20040138473A1 (en) 2004-07-15
US20040138474A1 (en) 2004-07-15
DE60331257D1 (en) 2010-03-25
ES2338871T3 (en) 2010-05-13
TW200412341A (en) 2004-07-16
EP1583748A4 (en) 2006-12-06

Similar Documents

Publication Publication Date Title
EA200500723A1 (en) COMPOUNDS OF BENZOFURANE, COMPOSITIONS AND METHODS OF TREATMENT AND PREVENTION OF INFECTIONS, CAUSED BY THE HEPATITIS C VIRUS, AND RELATED DISEASES
BRPI0412251A (en) treatment of environmental contaminants
TW200700401A (en) Process for preparing an epoxide starting from a chlorohydrin
NO20062644L (en) DPP-IV inhibitors
EA200400368A1 (en) NEW DIHYDROPTERIDINONES, METHODS FOR THEIR PRODUCTION AND THEIR USE AS MEDICINES
BRPI0519106A2 (en) compounds, their use, process for their manufacture, pharmaceutical compositions, method for the treatment and / or prophylaxis of diseases that are associated with dpp-iv
CY1110007T1 (en) METHOD OF PREPARATION OF ZONISAMID CRYSTALS RELEASED FROM 1,2-Dichloroethane and ZONISAMID CRYSTALS WITH HIGH HIGH DEPTH
EA200000358A1 (en) METHOD OF OBTAINING DIRYRLYPYRIDINES USEFUL AS COX-2 INHIBITORS
DE60236528D1 (en) LOW-TINTED SODIUM ARM BENZOXAZINONE UV ABSORBERS AND METHOD OF PREPARING THEM
MA27554A1 (en) PROCESS FOR THE PURIFICATION OF DIACEREIN.
DE60120273D1 (en) Polyvinyl alcohol film and polarizing film
EA200300597A1 (en) BIPHENYLKARBOXAMIDES USEFUL AS A REDUCING CONTENT OF AGENT LIPIDS
TW200634447A (en) Method of treating waste developing solution
ATE368091T1 (en) ELECTROLUMINESCENCE DEVICE AND METHOD FOR PRODUCING SAME
JP2008540413A5 (en)
EA199900948A1 (en) Method of producing 2-aryl-3-aryl-5-halogenpyridines used as COX-2 inhibitors
DE602004014264D1 (en) PROCESS FOR THE PRODUCTION OF OLANZAPINE
AR071580A1 (en) IMPROVED PROCESS OF PURIFICATION OF SUCRALOSE
DE60307494D1 (en) PROCESS FOR REDUCING RESTALCOOLOLS IN THE CRYSTALLINE VALACYCLOVIR HYDROCHLORIDE
ATE234826T1 (en) METHOD FOR STORAGE STABILIZATION OF COMPOUNDS WITH OXETANE RINGS
ATE522219T1 (en) COMPOSITIONS FOR INHIBITING OR TREATING HEPATITIS C VIRUSES
BRPI0407448A (en) Chemical process
EA199801084A1 (en) HOW TO OBTAIN PHENYL-HETEROCYCLIC COMPOUNDS USED AS CYCLOOXYGENASE-2 INHIBITORS
DE602006003204D1 (en) Purification method of moxonidine
BR0112064A (en) Process for the preparation of quinoline derivatives